PSYENCE BIOMEDICAL LTD. (PBM) — research page
US · us-cm-kg/NASDAQ/PBM · as of 2026-11-08
Identity and listing
PSYENCE BIOMEDICAL LTD. is listed on NASDAQ under ticker PBM. Its ISIN is US74449F4072. Its LEI is not on the record: there is no GLEIF record with the exact legal name in jurisdiction US-A6. Its security type is Non-operating entity type (other). Its segment is not on the record. Its sector is 2834 Pharmaceutical Preparations and its jurisdiction is Ontario, Canada. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | PSYENCE BIOMEDICAL LTD. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | PBM | source · 2026-11-08 |
| ISIN | US74449F4072 | source · 2026-10-06 |
| LEI | not on the record | |
| security type | Non-operating entity type (other) | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | Ontario, Canada | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 38 filings in the twelve months from 2025-11-08 to 2026-11-08, across 32 filing days: 3 prospectus, 9 regulatory filing and 26 results. The median gap between filing days is 6 days. The latest filing is dated 2026-10-21 and is a results filing, 18 days before the record date of 2026-11-08, and the median latency for this record is not stated on the issuer line. On NASDAQ the median filings count is 52, the median cadence gap is 6.0 days and the median latency is 5.0 days across 4359 issuers. In the sector 2834 Pharmaceutical Preparations the median filings count is 63.0, the median cadence gap is 6.0 days and the median latency is 4.0 days across 526 issuers. The issuer's 38 filings are below the NASDAQ median of 52 and below the sector median of 63.0. The issuer's latency of 18 days is above the NASDAQ median of 5.0 days and above the sector median of 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 38 | 6 | 18 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-21 | results | 6-K | 6-K — REPORT OF FOREIGN PRIVATE ISSUER |
| 2026-10-15 | regulatory_filing | SCHEDULE 13D/A | SCHEDULE 13D/A |
| 2026-10-05 | results | 6-K | 6-K — REPORT OF FOREIGN PRIVATE ISSUER |
| 2026-10-05 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
| 2026-09-28 | results | 6-K | 6-K — REPORT OF FOREIGN PRIVATE ISSUER |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record: there is no dei:AuditorName tag on the latest annual report cover, as foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's own investor-relations page, so the count is 0.
Open research
No openly published research notes were found, so the count is 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer's years sealed are 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001985062.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/PBM (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://mcp.us-cm-kg.ai/record/NASDAQ/PBM (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US74449F4072"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:4d654b3e156657ac.